| 1 |
Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management [J]. Am J Hematol, 2019, 94(10): 1149-1167.
|
| 2 |
中华医学会血液学分会白血病淋巴瘤学组. 嗜酸粒细胞增多症诊断与治疗中国专家共识(2017年版) [J]. 中华血液学杂志, 2017, 38(7): 561-565.
|
| 3 |
Ogbogu PU, Bochner BS, Butterfield JH, et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy [J]. J Allergy Clin Immunol, 2009, 124(6): 1319-1325. e3.
|
| 4 |
高汉林, 卢宇轩, 黄一宁, 等. 高嗜酸性粒细胞增多症与缺血性卒中关系的研究进展 [J]. 中华神经科杂志, 2022, 55(7): 770-774.
|
| 5 |
Tong LS, Wan JP, Cai X, et al. Global hypoperfusion: a new explanation of border zone strokes in hypereosinophilia [J]. CNS Neurosci Ther, 2014, 20(8): 794-796.
|
| 6 |
Aida L, Parkhutik V, Tembl JI, et al. Embolism and impaired washout: a possible explanation of border zone strokes in hypereosinophilic syndrome [J]. J Neurol Sci, 2013, 325(1/2): 162-164.
|
| 7 |
Miethe K, Iordanishvili E, Habib P, et al. Imaging patterns of cerebral ischemia in hypereosinophilic syndrom: case report and systematic review [J]. Neurol Sci, 2022, 43(8): 5091-5094.
|
| 8 |
Wang SA, Orazi A, Gotlib J, et al. The international consensus classification of eosinophilic disorders and systemic mastocytosis [J]. Am J Hematol, 2023, 98(8): 1286-1306.
|